Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protocol for analysis of intracellular conversion of artezomib molecules into new proteasome inhibitors in Plasmodium falciparum parasites

STAR Protocols(2024)10.1016/j.xpro.2024.102896Source: DataRank Database

Protocol for analysis of intracellular conversion of artezomib molecules into new proteasome inhibitors in Plasmodium falciparum parasites is a research paper published in STAR Protocols (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Yi Jing Liu,Laura A. Kirkman ORCID,Gang Lin ORCID,Wenhu Zhan ORCID

Live enrichment

PubMed:38363687 PMC:PMC10877166 OpenAlex:https://openalex.org/W4391920922

NIAID

Grant: R01AI143714

NIAID

Grant: R01AI177635

NIAID

Grant: R21AI153485

National Institutes of Health

Grant: 5R01AI143714-05

Selective Plasmodium proteasome inhibitors as novel multi-stage antimalarials

National Institutes of Health

Grant: 5R01AI177635-03

Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance

National Institutes of Health

Grant: 1R21AI153485-01

Compounds that force Plasmodium falciparum to produce its own inhibitors

National Institutes of Health

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xpro.2024.102896

publisherhttps://doi.org/10.1016/j.xpro.2024.102896

publisherhttps://api.elsevier.com/content/article/PII:S2666166724000613?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166724000613?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38363687

Fields of Study

Malaria Research and ControlMosquito-borne diseases and controlHIV Research and Treatment0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsPlasmodium falciparumParasitesProteasome InhibitorsProteasome Endopeptidase ComplexAntimalarialsArtemisinins

MeSH Terms

AnimalsAntimalarialsParasitesPlasmodium falciparumArtemisininsProteasome Endopeptidase ComplexProteasome Inhibitors

Keywords

ProteasomePharmacophorePlasmodium falciparumArtemisininIntracellularParasite hostingChemistryUbiquitinCell biologyMalariaBiologyBiochemistryImmunologyGeneComputer scienceMicrobiologyProteasome Endopeptidase ComplexScience (General)ArtemisininsQ1-390AntimalarialsProtocolAnimalsParasitesProteasome Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger